NASDAQ:RARE | Net Income | Ultragenyx Pharmaceutical Inc.

Complete source-backed net income history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$92M
2026-03-31-$185M
2025-12-31-$128.56M
2025-09-30-$180.41M
2025-06-30-$115M
2025-03-31-$151M
2024-12-31-$133.2M
2024-09-30-$133.52M
2024-06-30-$131.6M
2024-03-31-$170.68M
2023-12-31-$123.55M
2023-09-30-$159.65M
2023-06-30-$159.83M
2023-03-31-$163.97M
2022-12-31-$151.83M
2022-09-30-$245.11M
2022-06-30-$158.16M
2022-03-31-$152.32M
2021-12-31-$122.46M
2021-09-30-$73M
2021-06-30-$122.43M
2021-03-31-$136.14M
2020-12-31-$24.01M
2020-09-30-$68.85M
2020-06-30$25.32M
2020-03-31-$119.03M
2019-12-31-$93.81M
2019-09-30-$112.99M
2019-06-30-$99.17M
2019-03-31-$96.76M
2018-12-31-$87.83M
2018-09-30-$87.31M
2018-06-30-$52.73M
2018-03-31$30.25M
2017-12-31-$81.73M
2017-09-30-$79.23M
2017-06-30-$72.89M
2017-03-31-$68.29M
2016-12-31-$71.29M
2016-09-30-$64.91M
2016-06-30-$56.92M
2016-03-31-$52.76M
2015-12-31-$55.22M
2015-09-30-$39.23M
2015-06-30-$29.79M
2015-03-31-$21.38M
2014-12-31-$16.74M
2014-09-30-$15.85M
2014-06-30-$13.59M
2014-03-31-$13.63M
2013-12-31-$11.32M
2013-09-30-$8.43M
2013-06-30-$8.59M
2013-03-31-$6.74M

Annual Net Income

DateNet Income
2025-12-31-$575M
2024-12-31-$569M
2023-12-31-$607M
2022-12-31-$707.42M
2021-12-31-$454.03M
2020-12-31-$186.57M
2019-12-31-$402.73M
2018-12-31-$197.61M
2017-12-31-$302.14M
2016-12-31-$245.87M
2015-12-31-$145.62M
2014-12-31-$59.8M
2013-12-31-$35.07M
2012-12-31-$16.33M